2012 Annual Meeting | Pediatric Pseudotumor Cerebri: From Diagnosis to Treatment

��ɫ��

2012 Annual Meeting | Pediatric Pseudotumor Cerebri: From Diagnosis to Treatment

Date Saturday 04/28/12

Time 06:30 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Shawn C. Aylward, MD

Topic(s) Neuro-ophthalmology/Neuro-otology

Learning Objectives Participants should be able to identify at-risk patients in the office setting and should feel comfortable with initiating the diagnostic workup and management of patients found to have pseudotumor cerebri.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic

Program Evaluations

Event Timeline
06:30 AM - 06:45 AM		Dispelling the Myths of Pediatric Pseudotumor Cerebri Shawn C. Aylward, MD
06:30 AM - 08:30 AM
06:45 AM - 07:25 AM		Signs, Symptoms, and Mimics of Pseudotumor Cerebri in Children E. S. Roach, MD, FAAN
07:25 AM - 07:30 AM		Break
07:30 AM - 08:15 AM		Diagnosis, Treatment, and Anticipated Outcomes in Pediatric Pseudotumor Cerebri Shawn C. Aylward, MD
08:15 AM - 08:30 AM		Questions and Answers Shawn C. Aylward, MD, E. S. Roach, MD, FAAN

Faculty Disclosures
Shawn C. Aylward, MD	Dr. Aylward has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. The institution of Dr. Aylward has received research support from Pfizer. Dr. Aylward has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Vaccine injury counsel.
E. S. Roach, MD, FAAN	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��